Track topics on Twitter Track topics that are important to you
Alnylam Pharmaceuticals, an RNAi therapeutics company, has announced the expansion of its global footprint with the opening of a new development and commercial hub in Maidenhead, U.K. In anticipation of substantial growth across Alnylam over the next five years, the office opens with a core clinical development, regulatory affairs and commercial team and space for […]
The post Alnylam opens new European office in Maidenhead, UK appeared first on CenterWatch News Online.
Original Article: Alnylam opens new European office in Maidenhead, UKNEXT ARTICLE